AII
BIIB icon

AGF Investments Inc’s Biogen BIIB Stock Holding History

AGF Investments Inc’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,496
Closed -$359K – 459
2021
Q4 		$359K Buy
+1,496
New +$385K ﹤0.01% 547
2021
Q2 		– Sell
-1,101
Closed -$308K – 733
2021
Q1 		$308K Sell
1,101
-3,216
-74% -$867K ﹤0.01% 545
2020
Q4 		$1.06M Buy
4,317
+1,266
+41% +$327K 0.01% 389
2020
Q3 		$866K Buy
3,051
+102
+3% +$28.4K 0.01% 384
2020
Q2 		$789K Sell
2,949
-295
-9% -$88.7K 0.01% 382
2020
Q1 		$1.03M Buy
+3,244
New +$984K 0.01% 317
2015
Q2 		– Sell
-103,786
Closed -$43.8M – 455
2015
Q1 		$43.8M Buy
+103,786
New +$40.9M 0.48% 78

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

AGF Investments Inc's BIIB Position: Q1 2022 in Review

AGF Investments Inc sold out of Biogen (BIIB) in Q1 2022, closing a stake of 1,496 shares — an estimated $359K sold.

AGF Investments Inc first reported a position in BIIB in Q1 2015 and held it in 7 quarters. The position peaked at $43.8M in Q1 2015. 952 funds tracked by Wall St. Rank hold BIIB as of Q1 2022.

  • AGF Investments Inc reported no remaining Biogen position as of Q1 2022 after selling out during the quarter.
  • AGF Investments Inc sold 1,496 Biogen shares in Q1 2022, an estimated $359K.
  • AGF Investments Inc first reported a position in Biogen in Q1 2015 and held it in 7 quarters.
  • AGF Investments Inc's Biogen position peaked at $43.8M in Q1 2015.
  • 952 funds tracked by Wall St. Rank held Biogen as of Q1 2022.

Based on AGF Investments Inc's 13F filing for Q1 2022, filed 10 May 2022.